DaVita
DVA
#2032
Rank
C$13.71 B
Marketcap
C$205.13
Share price
1.66%
Change (1 day)
-7.04%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$14.03

According to DaVita's latest financial reports the company's current EPS (TTM) is C$13.86. In 2024 the company made an earnings per share (EPS) of C$15.11 an increase over its 2023 EPS that were of C$10.42.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.03-7.15%
2024C$15.1144.94%
2023C$10.4227.26%
2022C$8.19-35.56%
2021C$12.7144.1%
2020C$8.8219.7%
2019C$7.37540.48%
2018C$1.15-76.07%
2017C$4.81-19.31%
2016C$5.96242.52%
2015C$1.74-62.87%
2014C$4.6813.43%
2013C$4.138.45%
2012C$3.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$29.24 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$14.04 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$20.13 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.60-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA